Shao Y, Zhang J, Feng Z, Wu W, et al. Outcomes in non-small cell lung cancer with uncommon epidermal growth factor receptor L858 substitutions under first-line epidermal growth factor receptor tyrosine kinase inhibitors: A large real-world cohort study. Cancer Sci 2024 Jun 26. doi: 10.1111/cas.16250.
PMID: 38932450